Report cover



Drug Labeling in Developing Countries
GPO stock #052-003-01314-2
NTIS order #PB93-163343





Full Report ~2069K

. . . . .

Front Matter ~95K
Table of Contents ~111K

Chapters
1: Summary and Options ~270K
2: OTA Survey and Evaluation Process ~117K
3: Results of the OTA Survey ~434K
4: Drug Prescribing Information in the United States and Other Countries ~291K
5: Multinational Pharmaceutical Corporations and U.S. Extraterritorial Jurisdiction ~215K
6: Codes of Conduct and Voluntary Guidelines for Pharmaceutical Information ~161K
7: Efforts to Improve Drug Information In Developing Countries ~281K

Appendices
A: Major Studies of Pharmaceutical Labeling in Developing Countries ~105K
B: Drug Registration and Labeling in Brazil, Kenya, Panama, and Thailand ~98K
C: Acknowledgements ~78K
References ~529K
Index ~95K


Jump to: The OTA LegacyJump to: OTA & Congress
Jump to: OTA PublicationsJump to: About this site...